3',4'-Methylenedioxy-α-pyrrolidinopropiophenone
3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a synthetic stimulant of the cathinone class. It is structurally related to other compounds such as MDPV and α-PVP, and is known for its psychoactive effects. MDPPP is a designer drug that has been encountered in the recreational drug market.
Chemical Structure and Properties[edit]
MDPPP is characterized by the presence of a methylenedioxy group attached to the phenyl ring, which is a common feature in many psychoactive compounds. The chemical structure of MDPPP includes a pyrrolidine ring, which is a five-membered nitrogen-containing ring, attached to the α-carbon of the propiophenone backbone.
The molecular formula of MDPPP is C14H17NO3, and it has a molar mass of 247.29 g/mol. The presence of the methylenedioxy group is thought to contribute to its psychoactive properties by affecting the compound's interaction with neurotransmitter systems in the brain.
Pharmacology[edit]
MDPPP acts as a stimulant by increasing the levels of certain neurotransmitters in the brain, primarily dopamine and norepinephrine. This action is similar to that of other cathinones and is responsible for the drug's stimulating and euphoric effects. The exact mechanism of action is not fully understood, but it is believed to involve the inhibition of monoamine transporters, leading to increased synaptic concentrations of these neurotransmitters.
Effects and Risks[edit]
The effects of MDPPP are similar to those of other stimulant drugs and can include increased energy, alertness, and euphoria. However, the use of MDPPP also carries significant risks, including the potential for addiction, cardiovascular problems, and neurotoxicity. Adverse effects may include anxiety, paranoia, and hallucinations, particularly at higher doses.
Legal Status[edit]
The legal status of MDPPP varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is often included in legislation targeting synthetic cathinones and other designer drugs.
Synthesis[edit]
The synthesis of MDPPP involves the reaction of 3,4-methylenedioxyphenyl-2-propanone with pyrrolidine in the presence of a reducing agent. This process is similar to the synthesis of other cathinones and requires specialized knowledge and equipment.
Related Compounds[edit]
MDPPP is part of a larger class of compounds known as substituted cathinones, which are derivatives of the naturally occurring stimulant cathinone. Other related compounds include MDPV, α-PVP, and mephedrone. These compounds share similar chemical structures and pharmacological effects.
